Daniel Spratt, Chair and Professor of Radiation Oncology at Case Western Reserve University, shared a post on X:
“NRG Oncology Rtog 0924 trial on 2500 patients testing whole pelvic RT.
Negative trial
- OS no difference
- PCSM no difference
- DM no difference
- BCR was not SS different with only 4% difference at 10 years.
- toxicity increased
3 cooperative group trials now negative: getug01, Rtog 9413, Rtog 0924.
Goodbye WPRT”
More from Daniel E Spratt on OncoDaily.